Clinical trial
A Prospective Observational Study of Safety and Occurrence of Influenza-like Illness Following Administration of Adjuvanted Swine Origin A(H1N1) Pandemic Subunit Vaccine Focetria
NCT01040741 is registered in ClinicalTrials.gov with Novartis Vaccines as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Observational Study of Safety and Occurrence of Influenza-like Illness Following Administration of Adjuvanted Swine Origin A(H1N1) Pandemic Subunit Vaccine Focetria
- Lead sponsor
- Novartis Vaccines
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2009
- Completion date
- March 31, 2011
- Enrollment
- 7,284 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
a new flu virus of swine origin, pandemic influenza a (h1n1)